| 000 | 01609 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512054845.0 | ||
| 264 | 0 | _c19870824 | |
| 008 | 198708s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/s0022-5347(17)43138-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohler, J L | |
| 245 | 0 | 0 |
_aSuppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cAug 1987 |
||
| 300 |
_a336-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Infective Agents, Urinary _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Combinations _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSulfamethoxazole _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTrimethoprim _xtherapeutic use |
| 650 | 0 | 4 | _aTrimethoprim, Sulfamethoxazole Drug Combination |
| 650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xtherapy |
| 650 | 0 | 4 |
_aUrinary Catheterization _xadverse effects |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xdrug therapy |
| 700 | 1 | _aCowen, D L | |
| 700 | 1 | _aFlanigan, R C | |
| 773 | 0 |
_tThe Journal of urology _gvol. 138 _gno. 2 _gp. 336-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-5347(17)43138-7 _zAvailable from publisher's website |
| 999 |
_c3502197 _d3502197 |
||